Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Citi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2015-03-11 23:10:33 |
Versijas komentārs | |
Teksts |
Fourth Quarter 2014 Investor Conference Webinar
On March 11 AS „Olainfarm”
organized its fourth quarter 2014 Investor Conference Online
Webinar. During the webinar the member of the management board of
AS „Olainfarm” Salvis Lapiņš analyzed the financial results of
fourth quarter 2014 and non-audited financial results of 12 months
2014 and informed about the company’s future activities, paying
extra attention to company’s home market - Latvia.
During the webinar Salvis Lapiņš
said that with the aim to mitigate the effect the recession of
Russia company continues to move its marketing effort into smaller
regions of Russia. In 2015 minor sales increase is planned in
Russia compared to 2014.
Answering to the question of loans
given to Management, Salvis Lapiņš noted that repayment schedule is
being developed and in around 3 years the loan should be
repaid.
The recorded “Olainfarm” webinar is available online:
bit.ly/1AjfhKU,
and the presentation, demonstrated during the webinar, can be found
in the attachment.
Olainfarm thanks all
participants, who joined the webinar, and encourages everybody to
follow company’s announcements to get information on the next
webinar! JSC Olainfarm is one of the
biggest pharmaceutical companies in Latvia with more than 40 years
of experience in production of medication and chemical and
pharmaceutical products. A basic principle of company's operations
is to produce reliable and effective top quality products for
Latvia and the rest of the world. Products made by the Group are
being exported to more than 35 countries of the world, including
the Baltics, Russia, other CIS, Europe, Asia, North America and
Australia
Information prepared
by: Salvis Lapins |
Pielikumi |